Atlas Trials

A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Clinical trial NCT06815965 · COMPLETED

Trial details

NCT number
NCT06815965
Sponsor
EIP Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dementia With Lewy Bodies (DLB)
Start date
2024-10-16
Primary completion
2026-03-11
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.